Clinicians must consider protein binding when prescribing medications to pediatric patients. Monitoring drug levels, especially for narrow-therapeutic-index drugs, is crucial. Adjustments based on age, disease state, and individual response can optimize therapeutic outcomes and minimize adverse effects.
